Low-value care practice in headache: a Spanish mixed methods research study by Pozo Rosich, Patricia et al.
RESEARCH ARTICLE Open Access
Low-value care practice in headache: a
Spanish mixed methods research study
Patricia Pozo-Rosich1,2, Almudena Layos-Romero3, Jimmy Martin-Delgado4* , Julio Pascual5,6, Cristina Bailón5,
Ana Tentor7, Alejandro Santiago8, Emilio Ignacio9, Antonio Torrés10 and José Joaquín Mira11,12
Abstract
Background: Headache is one of the most prevalent diseases. The Global Burden of Disease Study ranks it as the
seventh most common disease overall and the second largest neurological cause of disability in the world. The “Do
Not Do” recommendations are a strategy for increasing the quality of care and reducing the cost of care for
headache. This study aimed to identify specific low-value practices in headache care, determine their frequency,
and estimate the cost overrun that they represent, in order to establish “Do not Do” recommendations specifically
for headache by consensus and according to scientific evidence.
Methods: This was a mixed methods research study that combined qualitative consensus-building techniques,
involving a multidisciplinary panel of experts to define the “Do Not Do” recommendations in headache care, and a
retrospective observational study with review of a randomized set of patient records from the past 6 months in four
hospitals, to quantify the frequency of these “Do Not Do” practices. We calculated the sum of direct costs of
medical consultations, medicines, and unnecessary diagnostic tests.
Results: Seven “Do Not Do” recommendations were established for headache. In total, 3507 medical records were
randomly reviewed. Low-value practices had a highly variable occurrence, depending on the hospital and type of
headache. Overall, 34.1% of low-value practices were related to treatment, 21% were related to overuse of imaging
in consultation, and 19% were related to emergency care. The estimated cost of low-value practices in the four
hospitals was 203,520.47 euros per 1000 patients.
Conclusions: This study identified low-value headache practices that need to be eradicated and provided data on
their frequency and cost overruns.
Keywords: Care, Cost, Do not Do recommendations, Headache, Patient safety, Mixed methods
Introduction
Headache is one of the most prevalent diseases and one
of the main reasons for consultation in primary care and
neurology services [1]. The prevalence of headache is
around 51% and, in Spain, it has been estimated that
more than four million people suffer from migraine. Of
these, one million suffer from chronic migraine [2, 3].
The Global Burden of Disease Survey [4] ranked head-
ache as the seventh most common disorder causing the
greatest decrease in quality of life in years. When consid-
ering only neurological diseases, migraine is the second
most common disabling condition, after stroke. Accord-
ing to the World Health Organization (WHO), head-
aches are one of the most disabling health problems
with the highest socioeconomic impact, since they are
responsible for the inactivity of sufferers during the most
productive years of their lives [5, 6].
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The Global Campaign against Headache, led by Lifting
the Burden, together with the WHO, aims to reduce the
gap in organizational, diagnostic, and therapeutic ap-
proaches to headache worldwide, and particularly in
Europe, and seeks to identify the quality dimensions of
headache care that should be considered in order to pro-
vide integrated quality care [7, 8]. The Eurolight study
analyzed the organization and treatment of patients with
migraine in Europe and estimated that the annual cost
of care for headache patients is 173,000 million euros
[9]. Migraine accounts for 64% of this total cost (110,000
million euros). Spain ranks second in Europe in terms of
the direct annual cost of headache [10]. The 2018 Atlas
of Migraine in Spain estimated that the annual total dir-
ect cost per patient for healthcare services was 3847.29
euros for chronic migraine and 964.19 euros for episodic
migraine. To these amounts must be added the cost as-
sumed by the patient, which ranges from 1657.96 euros
for chronic migraine and 878.04 euros for episodic mi-
graine; and the indirect cost associated with the inability
to work for this reason, which has been estimated at
7464.83 euros for chronic migraine and 3199.15 euros
for episodic migraine. The total cost per patient per year
comes to 12,970.08 euros for chronic migraine and
5041.38 euros for episodic migraine [11].
Overuse is defined as “the provision of medical ser-
vices for which the potential for harm exceeds the po-
tential for benefit” [12]. Ultimately, overuse can be
considered to occur along a continuum. At one end of
the continuum lie tests and treatments that are univer-
sally beneficial when used for the appropriate patient. At
the other end of the continuum are services that are en-
tirely ineffective, futile, or that possess such a high risk
of harm to all patients that they should never be deliv-
ered. Most procedures and interventions lie between
these extremes, and consensus is needed to help eluci-
date whether these procedures and interventions should
be recommended, and to help decide which patient they
may benefit [13].
The “Less is More,” “Right Care,” “Choosing Wisely,”
or “Do Not Do Recommendations” campaigns have
sought to establish consensus criteria to identify prac-
tices that have low value in health care, in an effort to
reduce them. Locally, the “Commitment for the Quality
of Care of the Scientific Societies in Spain,” of which 49
scientific societies form part, have elaborated a list of
recommendations, each one in its specialty or specific
field, about what should not be done following the
methodology of “Choosing Wisely.” In this case, there is
only one recommendation for headache care in Spain
(Do not Do neuroimaging studies repeatedly in patients
with primary headache (migraine and tension headache)
without changes in their profile [14]). Although scientific
societies internationally have established consensus
regarding the overuse of imaging tests or treatments that
should be avoided, there is still room to justify the im-
portance of reaching agreements regarding other prac-
tices that do not add value to specific headache care.
In this study, we aimed to identify specific low-value
practices in headache care, determine their frequency,
and estimate the cost overrun that they represent. “Do
not Do” recommendations specifically for headache were
established by consensus and according to scientific
evidence.
Methods
This was a mixed methods research study that combined
qualitative consensus-seeking techniques, involving a
multidisciplinary panel of experts, to define “Do not Do”
practices in headache, and a retrospective observational
study, with review of a random set of medical records
from four hospitals to quantify the frequency of these
“Do not Do” practices. This study was conducted be-
tween June and December 2019.
Review of the literature
To prepare for the working session with the panel of ex-
perts, a narrative review of the literature was carried out
after searching the following databases: PubMed, Scopus,
and EMBASE. The following search terms were used:
“headache,” “migraine,” “neuroimaging,” “Global Cam-
paign Against Headache,” “quality of care,” “do not do,”
“guidelines,” “treatment. Additionally, a manual search
was carried out on the websites of the following organi-
zations: Sociedad Española de Neurología, Atlas de
Migraña, Choosing Wisely USA, Choosing Wisely
Canada, Choosing Wisely Australia, American Headache
Society, International Headache Society, National Insti-
tute for Health and Care, and Scottish Intercollegiate
Guidelines Network (SIGN).
The titles and summary of the studies identified were
reviewed by two authors to decide whether they were
relevant to this study. The full text of the selected arti-
cles or documents was revised to extract information on
“Do not Do” recommendations in headache. The infor-
mation was included based on its level of evidence, and
feasibility of execution. It was agreed that the SIGN clas-
sification should be used as a guide to determine the
levels of evidence and degrees of recommendation. Prior
to the working session of the group of experts, the infor-
mation was organized according to the stage of the care
process, for example, diagnosis, evolution, treatment, or
control, and whether it was an emergency care situation
or a neurological consultation.
Group working session
The group of experts consisted of three specialists in
neurology, and one specialist each in family medicine,
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hospital pharmacy, and neurological nursing. The se-
lection of these panelists took into account the in-
volvement of professionals throughout the care
process, as well as their experience from the first
level of care to monographic consultations for head-
ache, as well as their specialized training. The work
of the panel of experts included a group session and
multiple telematic meetings until a sufficient degree
of consensus was reached. Experts had gathered
information during the literature review as well as
additional evidence that they could provide. In the
face-to-face meeting of the panel of experts, the rec-
ommendations identified in the literature review were
analyzed one-by-one. In parallel, experts proposed
and debated “Do not Do” recommendations associ-
ated with the headache care process in their areas of
expertise. JM and JJM produced a synthesis of the de-
bate and recorded recommendations through sum-
mary sheets that were analyzed individually by
successive rounds of telematic meetings, and thereby
“Do not Do” recommendations were identified. The
consensus on which “Do not Do” recommendations
should be proposed considered the quality of the evi-
dence for each recommendation, the feasibility in
identifying whether the undesirable practice was im-
plemented in clinical practice, and the foreseeable ac-
ceptance of the recommendation by the professional
community. Summary cards included the code of the
“Do not Do” recommendation, its definition, current
problem, number of instances of the undesirable prac-
tice occurring within a given number of consultations,
sources of information, and evidence.
Field study
We measured the frequency by which these low-value
or undesirable practices were implemented in an ob-
servational, retrospective, multicenter study. In this
study, 3507 clinical records of patients who attended
four university hospitals of the Spanish public health
system over the past 6 months were randomly
reviewed. A minimum required sample size of 3068
patients was calculated for a precision of 3%, p = q =
50% worst-case scenario, an expected proportion of
losses due to incomplete information of 15%, and a
confidence level (two-tailed) of 95%. The hospitals
had between 367 and 1146 beds. The review of clin-
ical records was carried out by applying algorithms
for data extraction from clinical information systems
that defined each of the “Do not Do” recommenda-
tions determined by consensus in the first part of the
study. The International Classification of Diseases
(ICD-10) and the Anatomical Therapeutic Chemical
Classification System (ATC) were used to select pa-
tients who had attended the hospital for headache.
Direct costs
Direct costs of ignoring this Do not Do recommenda-
tions were estimated by summing the estimated costs of
medical consultations, diagnostic tests, and medicines
associated with low-value practices. This estimate was
made considering the average costs of consultations and
diagnostic tests in the health services of Madrid, Castile
and Leon, and Murcia (based on data from 2017) and
the reference prices for financing medicines by the Na-
tional Health System in Spain described in Order SCB/
1244/2018. The average cost of the first consultations
was 82 euros, successive consultations were 71 euros,
and emergency care was 175 euros. Brain functional
studies with magnetic resonance imaging had an average
cost of 400 euros, and electroencephalogram 147 euros.
The overall direct cost of these low-value practices at
each center in the study period (6 months) was obtained
by multiplying the direct cost, in euros, of consultations,
tests, and medicines by the volume of patients with low-
value practices. Finally, considering a prevalence of 12–
13% for migraine, 2–3% for chronic migraine, and 51%
for headache [11], we extrapolated the total direct cost
for the Spanish healthcare system for the agreed low-
value indications, by multiplying the cost per patient by
the number of patients that could be expected to have
low-value indications according to our data.
Results
The literature review identified nine relevant studies
and three technical papers. Fourteen “Do not Do”
recommendations and two proposals for discussion by
the expert group were developed from this informa-
tion. Overall, the expert panel suggested 17 “Do not
Do” recommendations at the group work session
(supplementary file is available with all the recom-
mendations proposed by the expert panel). Finally,
seven “Do not Do” recommendations were prioritized
through telematic means based on the quality of the
evidence for each recommendation, the feasibility in
identifying whether the undesirable practice was im-
plemented in clinical practice (data extraction from
the clinical information systems contributes to this
identification), and the foreseeable acceptance of the
recommendation by the professional community. Full
details of these seven “Do not Do” recommendations
are available in Table 1.
The previous and only “Do not Do” recommendation
stablished for headache in the local context, was kept
and not only considered but it now approaches outpa-
tients and emergency care. In this consensus other rec-
ommendations from international organizations have
been considered and rephrased for the Spanish context,
for instance don’t use opioid or butalbital treatment for
migraine except as a last resort and don’t perform
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electroencephalography (EEG) for headaches [15]. Fi-
nally, three “Do not Do” recommendations were priori-
tized different from other previously stablished. These
recommendations were related with preventive treat-
ment drugs and its duration, and proper referral from
primary care to specialized care.
Review of the medical records revealed that consensus
“Do-not-Do” practices were implemented clinically in most
of the hospitals participating in this study, although with
varying frequency (Table 2). Practice NHC-02, involving
withdrawal of preventive treatment before 15 days, was the
most common, at 34.1% of the records reviewed. NHC-05,
related to correct referral from the first level to neurology,
had an occurrence of 4% and varied greatly between cen-
ters. Indicator data showed adequate use of diagnostic aids
along with correct use of opiates, NSAIDs, and acetamino-
phen. Even thought that it is important to point out the
high variability among hospitals in most of the “Do not do”
recommendations predominantly in NHC-02, 04 and 05.
Recommendations related to diagnostic tests or proce-
dures accumulated most of the avoidable expenses for the
healthcare system, even though there is widely agreement
on its low value in specific cases. Costs associated of ignor-
ing this “Do not Do” vary from 88,15€ to 429,00€ each
time it happens, depending on the average cost of the pro-
cedure or drug. NHC-02 which has been specially tailored
and prioritized for Spanish hospitals has an individual dir-
ect cost per patient of 142,57 €. If we extrapolated this
value to an estimated annual cost per 1000 patients of
these seven low-value or undesirable practices, we could
reach the amount of 203,520.47 euros (Table 3). If further
action is performed to prevent NHC-02 and NHC-04 up
to 75% of this expense could be saved.
Discussion
The concept of doing what is really needed rather than
focusing on what is dispensable (Right Care) has
gradually spread throughout health systems worldwide.
The results of this study indicate that there is significant
variability between centers in terms of the prescription
and use of diagnostic tests that do not provide value or
that may even be harmful to patients and emphasize the
need for intervention to avoid these low-value practices.
The “Do not Do” recommendations for headache care
developed by consensus in this study are supported by sci-
entific evidence and experience in daily clinical practice.
They address the entire care process, from correct referral
from the first level to neurology consultation [16], to the
overuse of neuroimaging without alarm criteria, defined in
the consultation or emergency department [17], the in-
appropriate use of neurophysiological studies [18], the
abuse of analgesic treatment [19, 20], the use of opioids
for primary headaches [21], and the withdrawal of pre-
ventive medication [22]. Although these “Do not Do” rec-
ommendations are similar to some previously published
by the American Headache Society [23] they have been
elaborated in the context of the Spanish public health sys-
tem, and are probably applicable to other national health
systems. Three recommendations related with preventive
treatment and a proper referral to specialized care could
be added to low-value care literature.
Our results highlight that implementing these “Do
not Do” practices not only jeopardize patient safety, but
also endanger the integrity and maintenance of the Na-
tional Health System. The main avoidable cost was re-
lated to non-recommended diagnostic tests, which may
also be attributed to the practice of defensive medicine
by practitioners, or to pressure from patients [24]. If we
extrapolate these results to the whole of the health sys-
tem in Spain, in terms of direct costs, this amounts to
an annual figure of approximately 615 million euros,
based on the last reported prevalence of 3,026,072
people diagnosed with migraine in 2015 [18].
Table 2 Frequency with which the consensus “Do not Do”
practices were implemented
Code Numerator (N) Denominator (N) Indicator (%) Range
NHC-01 53 3314 1.6 0–39.6
NHC-02 1136 3329 34.1 2.2–62.9
NHC-03 23 3329 0.7 0–8.3
NHC-04 694 3311 21.0 16.1–62.5
NHC-05 133 3326 4,0 0–58.2
NHC-06 635 3337 19,0 11–19.6
NHC-07 18 3361 0,5 0–8.8
Numerator: Number of patients with a certain diagnosis or condition who
have received a treatment or procedure that they should not have received;
cases of overuse defined by consensus of the expert group within a
given time period. Denominator: The number of patients with a given
diagnosis or condition who have been treated in the unit within a given
time period



















NHC-01 82,00 € 6,15 € 88,15 € 16 1.410,40 €
NHC-02 71,00 € 71,57 € 142,57 € 341 48.616,37 €
NHC-03 82,00 € 347,00 € 429,00 € 7 3.003,00 €
NHC-04 82,00 € 240,08 € 322,80 € 210 67.788,00 €
NHC-05 82,00 € - 82,00 € 40 3.280,00 €
NHC-06 175,0 0€ 240,08 € 415,80 € 190 79.002,00 €
NHC-07 82,00 € 2,14 € 84,14 € 5 420,70 €
A: Average consultation cost obtained from available information
B: Average cost of each diagnostic procedure or therapeutic guideline used
C: Total direct cost of low-value practices
D: Occurrence of “Do not Do” in 1000 patients
Pozo-Rosich et al. The Journal of Headache and Pain           (2020) 21:74 Page 6 of 8
The reduction of these practices with low diagnostic
or therapeutic value or of practices that are harmful to
patients has been achieved in some of the centers par-
ticipating in this study (for example, the use of opiates
for the treatment of primary headaches and the abuse of
analgesics) by incorporating criteria for carrying out ex-
aminations or for prescribing medication. It is important
to notice the high variability among the participating
hospitals. This is due that some services, hospitals, or
health areas in Spain can independently generate its own
measures to reduce low value care. This can be for one
instance the inability of prescribing opioids for headache
or the active blocking of CT scans for headaches without
alarm signs. This approach in implementation science
has been described as PRECEDE, in which there are
multiple factors, including knowledge, attitudes and be-
liefs (as predisposing factors), enabling factors, such as
active decision support and work flow innovations in
point-of-care tools as the electronic medical record and
finally reinforcing factors (motivation to sustain behavior
change) [24].
The literature reflects the outcome of interventions
based on communication of the benefit of following
these recommendations, acting on professional attitudes,
knowledge, and behavior, or on changes in patient de-
mands [25, 26]. For example, the results of the Choosing
Wisely campaign are inconsistent; while significant re-
ductions in some “Do not Do” practices have been
achieved, there has been no change in the implementa-
tions of others by professionals [27, 28]. These and other
findings on the level of awareness of these recommenda-
tions among professionals [29–31] suggest that more
effort is needed to make these “Do not Do” recommen-
dations known (also including campaigns directed at pa-
tients). They also emphasize that it is necessary not only
to identify and measure low-value practices, but also to
establish how to convey these results to the professionals
and specialists involved in headache. These first two
steps are essential for improving the quality of care pro-
vided and thereby reduce the cost of delivering such
care.
There are also other possible factors that modify the
compliment with “Do not Do” recommendations. Our
study doesn’t approached other causes related to sociode-
mographic and personal characteristics of patient and pro-
vider as they have been discussed in other studies [32].
These recommendations pursue the objective of im-
proving quality of healthcare and patient safety, and sim-
ultaneously lowering low value care. But “Do not Do”
recommendations can’t effectively fulfill this aim by its
own. It must be accompanied by other policies related
to patient safety and quality of care [33]. These measures
will backup physicians and allow them to provide better
health care. Also, other techniques can help healthcare
workers, for example watchful waiting [34]. A proper
and trustful communication, between provider and
patients have demonstrated in previous studies to im-
prove outcomes and lowering the incidence of low value
practice [25].
This study had some limitations. First, the quality of
the information recorded in the clinical records may
have led to under-identification of cases of overuse. Al-
though an algorithm was defined with specification of
diagnostic and therapeutic codes (numerators and de-
nominators) to record the same data in all centers, pos-
sible variability in coding between centers cannot be
ruled out. For ethical reasons, professionals could only
review the clinical history of patients from their own
center, and thus cross-validation of the overuse coding
was not possible.
Conclusion
In conclusion, the consensus “Do not Do” recommenda-
tions developed in this study are relevant to daily clinical
practice. We found that the incidence of low-value prac-
tices varied depending on the hospital and the type of
headache: there was greater variability in drug prescrip-
tion, and more similar results in the overuse of neuroim-
aging. This study provided data on low-value practices
in headache care, and also illustrated that a reduction of
these low-value practices is both possible and desirable.
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